{
    "root": "2124870a-c883-46ee-8f1d-bcb1c01ef301",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Nebivolol",
    "value": "20241031",
    "ingredients": [
        {
            "name": "NEBIVOLOL HYDROCHLORIDE",
            "code": "JGS34J7L9I"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        }
    ],
    "indications": "nebivolol beta-adrenergic blocking agent indicated treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 )",
    "contraindications": "taken without food . individualize needs patient monitor up-titration . ( 2 ) hypertension : patients start 5 mg daily . dose increased 2-week intervals 40 mg. ( 2.1 )",
    "warningsAndPrecautions": "nebivolol available tablets oral containing nebivolol hydrochloride equivalent 2.5 mg nebivolol . nebivolol tablets white white , round , biconvex , unscored tablet debossed `` c50 `` one side plain side . ndc : 72162-2415-3 : 30 tablets bottle store 20° 25°c ( 68° 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] . dispense tight , light-resistant containerasdefinedintheuspusing child-resistant closure . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "nebivolol tablets contraindicated following conditions : severe bradycardia heart block greater first degree patients cardiogenic shock decompensated cardiac failure sick sinus syndrome ( unless permanent pacemaker place ) patients severe hepatic impairment ( child-pugh > b ) patients hypersensitive component product .",
    "indications_original": "Nebivolol is a beta-adrenergic blocking agent indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.( 1.1 )",
    "contraindications_original": "Can be taken with and without food. Individualize to the needs of the patient and monitor during up-titration. ( 2 ) Hypertension: Most patients start at 5 mg once daily. Dose can be increased at 2-week intervals up to 40 mg. ( 2.1 )",
    "warningsAndPrecautions_original": "Nebivolol is available as tablets for oral administration containing nebivolol hydrochloride equivalent to 2.5 mg of nebivolol.\n                  Nebivolol tablets are white to off white ,round, biconvex, unscored tablet debossed with \"C50\" on one side and plain on the other side.\n                  NDC: 72162-2415-3: 30 Tablets in a BOTTLE\n                  Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F)\n                  [See USP Controlled Room Temperature].\n                  Dispense in a tight,light-resistant containerasdefinedintheUSPusing a child-resistant closure.\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "Nebivolol Tablets is contraindicated in the following conditions: \n                  \n                     Severe bradycardia\n                     Heart block greater than first degree \n                     Patients with cardiogenic shock \n                     Decompensated cardiac failure\n                     Sick sinus syndrome (unless a permanent pacemaker is in place) \n                     Patients with severe hepatic impairment (Child-Pugh >B)\n                     Patients who are hypersensitive to any component of this product."
}